Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dan Deng Tong Nao dropping pills
- Development stage
- Unknown
- Lead developer
- Guizhou Yibai Pharmaceutical
- Administration
- Oral
01
Overview
Dan Deng Tong Nao dropping pills (also known as Dandeng Tongnao Diwan) is an approved traditional Chinese medicine (TCM) formulation developed by Guizhou Yibai Pharmaceutical and its subsidiary Guizhou Yibai Women's Pharmacy. It is formulated as a dropping pill containing extracts from four key herbal ingredients: *Salvia miltiorrhiza* (Danshen), *Erigeron breviscapus* (Dengzhanxixin), *Ligusticum chuanxiong* (Chuanxiong), and *Pueraria lobata* (Gegen). The formulation is clinically used in China for the treatment of ischemic stroke, cerebral ischemia-reperfusion injury (CIRI), coronary heart disease, and angina pectoris. It exerts its therapeutic effects through promoting blood circulation, removing blood stasis, dispelling wind, and dredging collaterals, which helps improve cerebral microcirculation, reduce cerebral infarct volume, and protect brain microvascular endothelial cells.
- Other names
- Dan Deng Tong Nao Di WanDandeng Tongnao DiwanDandeng Tongnao dropping pills丹灯通脑滴丸
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)HMOX1 (Heme oxygenase 1)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NOS3 (eNOS)PIK3CA (Phosphoinositide 3-kinase alpha)
Beyond the preview
Go deeper on Dan Deng Tong Nao dropping pills.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dan Deng Tong Nao dropping pills.